His main research concerns Virology, Antibody, Epitope, Antigen and Monoclonal antibody. His Virology research includes themes of Immunogen and Immunology. His Antibody research integrates issues from Germline and Glycoprotein.
His biological study spans a wide range of topics, including HIV vaccine, Serology and Binding site. While the research belongs to areas of Antigen, Leonidas Stamatatos spends his time largely on the problem of B-cell receptor, intersecting his research to questions surrounding HIV envelope protein and Viral protein. His research combines Virus and Monoclonal antibody.
His primary areas of investigation include Virology, Antibody, Epitope, Neutralization and Virus. His Virology study combines topics in areas such as HIV vaccine, Immunology and Glycoprotein. His Antibody research is multidisciplinary, incorporating elements of Antigen and Germline.
His Epitope research incorporates themes from Viral envelope, B-cell receptor and Molecular biology. His work in Neutralization addresses subjects such as Mutant, which are connected to disciplines such as Consensus sequence and Mutation. Leonidas Stamatatos has researched Virus in several fields, including V3 loop and Heterologous.
Leonidas Stamatatos mainly investigates Antibody, Virology, Monoclonal antibody, Neutralization and Epitope. The Antibody study combines topics in areas such as Virus and Immune system. His studies deal with areas such as Serology and Polyclonal antibodies as well as Virology.
His Monoclonal antibody research is multidisciplinary, incorporating perspectives in Plasma protein binding, Somatic hypermutation, Fusion protein and Glycoprotein. His research integrates issues of Titer and In vivo in his study of Neutralization. He has included themes like Receptor and B-cell receptor in his Epitope study.
Leonidas Stamatatos mainly focuses on Antibody, Virology, Monoclonal antibody, Virus and Epitope. His work carried out in the field of Antibody brings together such families of science as Glycoprotein and Vaccination. His Glycoprotein study integrates concerns from other disciplines, such as B cell, Binding site, Plasma protein binding and Ectodomain.
The concepts of his Vaccination study are interwoven with issues in Serology, Priming, Immunogen and Polyclonal antibodies. His study in Virus is interdisciplinary in nature, drawing from both CRISPR, Immunity and Antigen. His Epitope study typically links adjacent topics like Germline mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Ming Li;Feng Gao;John R. Mascola;Leonidas Stamatatos.
Journal of Virology (2005)
Rational HIV immunogen design to target specific germline B cell receptors
Joseph Jardine;Jean Philippe Julien;Jean Philippe Julien;Sergey Menis;Takayuki Ota.
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather;Jakob Armann;Jakob Armann;Lance K. Ching;Lance K. Ching;Angeliki Mavrantoni;Angeliki Mavrantoni.
Journal of Virology (2009)
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Leonidas Stamatatos;Leonidas Stamatatos;Lynn Morris;Dennis R Burton;John R Mascola.
Nature Medicine (2009)
Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes.
Leonidas Stamatatos;Rania Leventis;Martin J. Zuckermann;John R. Silvius.
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Iliyana Mikell;D. Noah Sather;Spyros A. Kalams;Marcus Altfeld.
PLOS Pathogens (2011)
The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region
S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis.
Journal of Virology (2001)
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Leonidas Stamatatos;Leonidas Stamatatos;Julie Czartoski;Yu Hsin Wan;Leah J. Homad.
Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.
Emilie Seydoux;Leah J. Homad;Anna J. MacCamy;K. Rachael Parks;K. Rachael Parks.
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Andrew T. McGuire;Sam Hoot;Anita M. Dreyer;Adriana Lippy.
Journal of Experimental Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: